Why Is ASGN Incorporated (ASGN) Stock Down -45% Today?
Key Takeaways
-
Shares of ASGN are plunging approximately 45% in Thursday's session on April 23, 2026, declining from a prior close of $40.43 to approximately $22.24, following a devastating Q1 2026 earnings report and Q2 guidance that came in nearly 44% below analyst EPS consensus — one of the largest guidance misses in the company's history as a public company.
-
The primary catalyst is the Q2 2026 adjusted EPS guidance of $0.72–$0.90 issued after the April 22 close, versus the Street's consensus of $1.28 — a shortfall that implies a prolonged earnings contraction driven by declining commercial IT staffing revenue, margin compression, and macroeconomic headwinds.
-
Q1 2026 EPS of $0.69 also missed consensus of $1.00 by $0.31, while gross margin fell to 27.5% from 28.4% a year earlier, reflecting weaker commercial segment mix and FX-related pressure.
-
Multiple analysts responded by cutting price targets Thursday morning — Truist downgraded ASGN and lowered its target to $33, while UBS cut its target to $35 from $39 — further accelerating the institutional selling cascade.
-
The company simultaneously announced a planned corporate rebranding from ASGN Incorporated to Everforth, Inc., effective April 24, 2026, a strategic pivot that has done little to offset the negative earnings sentiment.
-
Traders will focus on whether the guidance trough represents a single-quarter reset or the beginning of a multi-quarter earnings decline cycle.
Opening Summary
ASGN Incorporated (ASGN) is a Richmond, Virginia-based provider of IT staffing, professional services, and digital transformation solutions to commercial enterprises and U.S. federal government agencies. The company serves clients across commercial and government verticals, offering technology consulting, IT workforce solutions, and digital engineering capabilities. In a separate announcement, ASGN disclosed it will rebrand to Everforth, Inc. on April 24, 2026. Shares are declining approximately 45% on Thursday, April 23, 2026, falling from a prior close of $40.43 to approximately $22.24 — the stock's largest single-session decline in recent memory. The selloff is a direct earnings-driven market reaction to Q1 2026 results and Q2 2026 guidance that collectively signaled a sharp deterioration in profitability that was entirely unanticipated by Wall Street consensus models.
Q1 2026 Earnings Miss and Margin Compression
ASGN's Q1 2026 results, released after the close on April 22, delivered a significant earnings miss across the most critical profitability metrics. The company reported adjusted EPS of $0.69 per share — missing analyst consensus of $1.00 by $0.31, or approximately 31%. Q1 revenue came in at $968.3 million, broadly in line with guidance but approximately $22.8 million below consensus of $991 million. More significantly, gross margin contracted to 27.5% from 28.4% in the year-ago quarter — a 90-basis-point compression that reflects a deteriorating commercial IT staffing mix, where lower-margin contract placements are displacing higher-margin consulting and solutions engagements. Adjusted EBITDA was $83.6 million, representing an 8.6% margin — below prior-year levels — and adjusted EBITDA guidance for Q2 of $85–$95 million suggests that margin recovery will be gradual at best.
Catastrophic Q2 2026 Guidance Miss
The most damaging element of the April 22 release is the Q2 2026 guidance, which represents a fundamental reset of Wall Street's earnings model for ASGN. The company guided Q2 adjusted EPS to $0.72–$0.90 — a range that compares to the analyst consensus of $1.28, implying a midpoint shortfall of approximately $0.49 per share, or nearly 44% below expectations. Q2 revenue guidance of $970 million to $1.0 billion bracketed the prior consensus, offering no top-line upside to offset the profitability shortfall. GAAP EPS guidance for Q2 was even weaker at $0.19–$0.33 per share. This guidance profile signals that the Q1 EPS miss was not a one-quarter anomaly but reflects a structural deterioration in ASGN's commercial segment profitability — a development that forces institutional investors to meaningfully reduce their full-year 2026 and 2027 earnings estimates and, by extension, their price targets.
Analyst Downgrades Accelerate Selling Pressure
The earnings miss and guidance cut triggered a swift and decisive analyst response on Thursday morning. Truist Securities downgraded ASGN and lowered its price target to $33, reflecting a fundamental re-rating of the stock's earnings trajectory. UBS reduced its price target to $35 from $39 while the analyst community more broadly recalibrated their models to reflect the new guidance. With the stock trading near $22 — well below even the newly reduced price targets — the gap between analyst estimates and market clearing prices indicates that the institutional consensus is struggling to anchor a bottom. The simultaneous announcement of the Everforth rebranding on April 24 appears to have provided no offsetting positive catalyst, as investors interpreted the strategic pivot as a narrative distraction from the underlying profitability challenges.
Market Context and Trading Activity
Volume in ASGN on April 23 is running dramatically above the 30-day average of approximately 490,000 shares, with millions of shares changing hands in early trading as the after-hours selloff of approximately 23% from Tuesday's close is translated into full price discovery in Thursday's regular session. The broader NYSE and Nasdaq are under moderate pressure Thursday, but ASGN's decline is entirely company-specific. Technically, the stock has broken well below its prior 52-week low of $34.59 — set as recently as March 2026 — and is now trading at price levels not seen in several years. The $290 million acquisition of Quinnox, completed in Q1 2026, adds leverage to the balance sheet at precisely the moment when near-term profitability has deteriorated, amplifying investor concerns about financial flexibility.
Trending AI Robots
For traders navigating the type of catastrophic earnings-driven gap-down events and multi-analyst downgrade cascades seen in ASGN today, Tickeron's Trending AI Robots page provides a curated view of the platform's strongest-performing AI trading bots under current market conditions. Tickeron operates hundreds of AI-driven bots covering thousands of tickers, but only those demonstrating the highest real-time performance are featured in this section. Bots span a wide range of strategy types, holding timeframes, risk profiles, performance metrics, and traded symbol universes — from reversal and mean-reversion systems suited for post-earnings dislocations to systematic, longer-timeframe strategies designed for steadier conditions in technology services equities. Whether you are managing risk around earnings-driven gaps or identifying structured setups elsewhere, the Trending AI Robots page is a practical starting point for AI-assisted trading.
What Comes Next for ASGN
The most immediate development for ASGN is the completion of its rebranding to Everforth, Inc., effective April 24, 2026 — though investors will require concrete evidence of improved financial performance rather than a name change to restore confidence. The company's next major catalyst is the Q2 2026 earnings release, expected in late July 2026, which will reveal whether management's guided range of $0.72–$0.90 in adjusted EPS proves achievable or optimistic. Key metrics to monitor include commercial segment gross margin recovery, the pace of Quinnox integration and its contribution to higher-value professional services revenue, and federal segment performance given ongoing U.S. government IT spending dynamics under the current administration's budget priorities. Key risks include a prolonged commercial IT staffing market downturn, further analyst estimate reductions if Q2 results disappoint, continued margin pressure from the unfavorable commercial mix shift, elevated post-acquisition debt service, and the rebranding execution risk of transitioning to Everforth while simultaneously managing financial headwinds.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
EFOR's RSI Oscillator leaves overbought zone
The 10-day RSI Oscillator for EFOR moved out of overbought territory on October 02, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 instances where the indicator moved out of the overbought zone. In 14 of the 18 cases the stock moved lower in the days that followed. This puts the odds of a move down at 78%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EFOR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
EFOR broke above its upper Bollinger Band on October 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 30, 2026. You may want to consider a long position or call options on EFOR as a result. In 60 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
The Moving Average Convergence Divergence (MACD) for EFOR just turned positive on October 01, 2026. Looking at past instances where EFOR's MACD turned positive, the stock continued to rise in 38 of 51 cases over the following month. The odds of a continued upward trend are 75%.
Following a +7.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where EFOR advanced for three days, in 175 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Aroon Indicator entered an Uptrend today. In 141 of 216 cases where EFOR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 29 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. EFOR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.746) is normal, around the industry mean (7.552). P/E Ratio (16.923) is within average values for comparable stocks, (68.701). Projected Growth (PEG Ratio) (1.450) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (0.345) is also within normal values, averaging (143.599).
The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EFOR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of in-demand, skilled professionals in the growing life sciences, healthcare, and technology sectors
Industry InformationTechnologyServices
Advertisement